Innate Pharma SA banner

Innate Pharma SA
PAR:IPH

Watchlist Manager
Innate Pharma SA Logo
Innate Pharma SA
PAR:IPH
Watchlist
Price: 1.66 EUR -1.19%
Market Cap: €155.9m

Intrinsic Value

The intrinsic value for Innate Pharma SA (IPH) under the Base Case is 0.52 EUR. Compared with the current market price of 1.66 EUR, the stock appears Overvalued by 68% .

IPH Intrinsic Value
0.52 EUR
Overvaluation 68%
Intrinsic Value
Price €1.66
Bear Case
Base Case
Bull Case
Monitor IPH
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €0.42
Get notified when the price drops into your buy zone
Current Price €1.66
Intrinsic Value €0.52
Margin of Safety 20% €0.42
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about IPH?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is IPH valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Innate Pharma SA.

Explain Valuation
Alternatives to IPH

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

IPH Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one IPH stock?

The intrinsic value for Innate Pharma SA (IPH) under the Base Case is 0.52 EUR.

Is IPH stock undervalued or overvalued?

Compared with the current market price of 1.66 EUR, the stock appears Overvalued by 68% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett